Key Takeaways
- Caregiver burden significantly impacts recruitment and retention in clinical trials, yet it often gets overlooked.
- Caregivers play crucial roles beyond support, including transportation, medication management, and emotional support.
- Traditionally, feasibility assessments neglect caregiver challenges, leading to impractical study protocols.
- Reducing caregiver burden can enhance participant satisfaction and trial outcomes, making study experiences more effective.
- Engaging caregivers early, simplifying trial materials, and providing support services can reduce burdens and improve study participation.
Patients carry the diagnosis. Caregivers often carry the burden.
Clinical trials often focus on reducing burden for patients. But in many therapeutic areas, especially rare disease, pediatric, neurology, and complex chronic conditions, another stakeholder is carrying an equally significant load: the caregiver.
When caregivers are overwhelmed, recruitment slows, retention suffers, protocol compliance becomes more difficult, and the participant experience deteriorates. Yet caregiver burden is frequently overlooked during study planning.
If sponsors want more patient-centered trials, they must start recognizing that many patients do not participate alone.
Caregivers Often Make Trial Participation Possible
For many participants, caregivers are far more than a support system. They are transportation coordinators, medication managers, appointment schedulers, advocates, note takers, and emotional support providers.
In pediatric trials, caregiver involvement is expected. In rare disease studies, caregivers may be responsible for managing nearly every aspect of participation. Even in adult indications, caregivers often play a critical role when mobility limitations, cognitive impairment, treatment complexity, or geographic challenges are involved.
The reality is simple: if participation creates an unsustainable burden on caregivers, many families will conclude that enrollment is not feasible.
The patient may be willing. The protocol may be scientifically sound. But if the caregiver cannot realistically support participation, recruitment stops before it starts.
The Hidden Costs of Caregiver Burden
Sponsors often account for participant travel and visit schedules when evaluating study feasibility. Less frequently considered are the secondary burdens placed on caregivers.
These can include:
- Lost work time
- Childcare arrangements
- Transportation coordination
- Financial expenses
- Emotional stress
- Management of household responsibilities
- Navigating healthcare systems and study requirements
None of these challenges appear in enrollment projections or operational dashboards. Yet they directly influence recruitment and retention outcomes.
When caregivers feel overwhelmed, the result may be:
- Missed study visits
- Reduced protocol adherence
- Increased withdrawal rates
- Delayed enrollment decisions
- Negative perceptions of the study experience
These outcomes are often viewed as operational challenges when they are actually indicators of caregiver strain.
Why Traditional Feasibility Assessments Miss the Problem
Most feasibility processes are designed to evaluate sites, investigators, timelines, and patient populations.
Far fewer evaluate the day-to-day realities faced by families.
Questions that are frequently overlooked include:
- How much time will caregivers spend coordinating participation?
- How far will they need to travel?
- How often will visits disrupt work or school schedules?
- Are study materials easy to understand and manage?
- What support resources exist when problems arise?
Without answers to these questions, sponsors risk designing protocols that appear practical on paper but become difficult to execute in the real world.
This is particularly common in rare disease research, where caregiver involvement is often extensive and prolonged.
Caregiver Burden Directly Impacts Retention
Recruitment receives significant attention, but retention is where caregiver burden often becomes most visible.
Families may initially commit to participation with optimism and determination. Over time, however, repeated visits, unexpected schedule changes, administrative requirements, and ongoing care responsibilities can accumulate.
What seemed manageable at enrollment may become overwhelming six months later.
Sponsors often investigate retention challenges by examining site performance or participant engagement. While these factors matter, caregiver fatigue is frequently an underlying contributor.
Reducing caregiver burden can therefore have a meaningful effect on retention outcomes, participant satisfaction, and overall study performance.
Building Trials That Work for Caregivers
Caregiver burden cannot be eliminated entirely, but it can be reduced through intentional study design.
Patient-centered sponsors increasingly consider strategies such as:
Engaging Caregivers Early
Caregivers provide perspectives that patients, investigators, and sponsors may not fully appreciate.
Their feedback can help identify obstacles before recruitment begins and reveal opportunities to simplify participation.
Simplifying Trial Materials
Complex consent forms, dense educational resources, and unclear instructions increase stress for both participants and caregivers.
Clear, health-literate materials can reduce confusion and improve confidence throughout the study journey.
Evaluating Visit Schedules Through a Family Lens
A protocol that appears reasonable from an operational perspective may create significant disruption for families.
Understanding real-world scheduling challenges can help sponsors identify opportunities to reduce unnecessary burden.
Providing Meaningful Support Services
Travel assistance, concierge services, referral management, and ongoing participant support can make participation more manageable for both patients and caregivers.
These resources do not simply improve convenience. They help remove barriers that would otherwise prevent participation.
The Most Patient-Centered Trials Are Also Caregiver-Centered
Patient centricity is often discussed as though it begins and ends with the participant.
In reality, many patients depend on caregivers to access, understand, and remain engaged in clinical research.
Sponsors who ignore caregiver burden risk creating studies that patients want to join but families cannot realistically support.
Sponsors who address caregiver needs from the beginning are more likely to improve recruitment, strengthen retention, and create experiences that participants view positively long after the trial ends.
The future of patient-centered research requires seeing the full support system around the patient.
That starts with recognizing caregivers as essential partners in clinical trial success.
Reduce Burden Before It Impacts Enrollment and Retention
Caregiver challenges are often uncovered too late, after recruitment slows or participants begin withdrawing from a study. Identifying these barriers during planning can help sponsors create more practical, participant-friendly experiences from the outset.
PAS helps sponsors evaluate participation burden, gather patient and caregiver insights, improve study materials, and develop engagement strategies that support recruitment and retention goals.
When trials work better for caregivers, they often work better for patients too.
Schedule a conversation to explore how caregiver-informed study design can strengthen your recruitment and retention strategy.
